Royal Philips has expanded its portfolio of sleep solutions by launching a new over-the-nose continuous positive airway pressure (CPAP) mask for sleep apnoea patients.
Called DreamWisp, the mask’s facial tube exits the mask to the side, rather than on the front as in traditional devices. This is designed to offer comfort and freedom of movement.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It is estimated that more than 100 million people suffer from obstructive sleep apnoea (OSA) worldwide. The discomfort caused by wearing CPAP masks is considered as one of the most common challenges for therapy adherence.
Patients that require an over-the-nose mask reportedly cite the front-facing tube as the primary reason for avoiding their sleep apnoea treatment. Royal Philips expects that the DreamWisp’s alternative tube design will address this issue.
Royal Philips sleep business leader Mark D’Angelo said: “Throughout the world, millions of people suffer from sleep apnea and many of them struggle to adhere to therapy because of mask discomfort.
“Designed with the patient in mind, DreamWisp helps sleep apnoea patients get the rest they deserve with the ability to sleep more comfortably.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“As we continue to expand our sleep portfolio, our focus remains on providing patients with comfortable solutions that help them improve their sleep and overall wellbeing.”
The company noted that 97% of clinicians that participated in a clinical trial said that they would recommend the CPAP mask.
Philips develops breathing and respiratory care solutions such as home oxygen systems, ventilators, respiratory drug delivery products, pulse oximetry devices and airway clearance devices.
